Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12188/33444| Title: | Pharmacotherapeutic options for the prevention of kidney transplant rejection: the evidence to date | Authors: | Spasovski, Goce Trajcheska, Lada Rambabova Bushljetic, Irena |
Keywords: | kidney transplantation calcineurin inhibitors belatacept everolimus sirolimus eculizumab clazakizumab tocilizumab |
Issue Date: | Aug-2022 | Publisher: | Informa UK Limited | Journal: | Expert Opinion on Pharmacotherapy | Abstract: | Although early rejection episodes are successfully controlled, the problem of unrecognized production of de novo anti-HLA antibodies and associated chronic rejection still persists. | URI: | http://hdl.handle.net/20.500.12188/33444 | DOI: | 10.1080/14656566.2022.2102418 |
| Appears in Collections: | Faculty of Medicine: Journal Articles |
Show full item record
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.